Axon Peptide: 20 Kovera certificates.
The lab's record shows 20 certificates printed for Axon Peptide, analysed between 20 May 2026 and 23 May 2026, covering 18 products. Median HPLC purity is 99.34%. Kovera graded 19 as a pass and 1 as a fail.
What the record shows
RETRIEVED 2 AUGUST 20262 of the 20 certificates meet at least one of our failure rules. They are shaded in the table below. 12 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera revised 7 of these certificates after first publication, under the same report number: KVR-2026-F2E8BC (revised by the lab 2026-06-09, figures unchanged); KVR-2026-A37790 (revised by the lab 2026-06-09, figures unchanged); KVR-2026-9AF638 (revised by the lab 2026-06-09, figures unchanged); KVR-2026-850CA6 (revised by the lab 2026-06-09, figures unchanged); KVR-2026-3FE373 (revised by the lab 2026-06-09, figures unchanged); KVR-2026-2DD1C5 (revised by the lab 2026-06-09, figures unchanged); KVR-2026-12AC8A (revised by the lab 2026-06-09, figures unchanged). Why that matters is in our revisions analysis.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
18 AS PRINTEDEvery certificate
NEWEST FIRST · 20 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-F2E8BC | GLOW Blend | AXP-TS-20260323-01-16-70 | 99.756% | 113.2%79.25 of 70 mg | 23 May 2026 | PASSover 110% of labelrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-9005A2 | GHK-Cu | AXP-TS-20260323-01-13-100 | 99.799% | 107.2%107.17 of 100 mg | 23 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3D9FF3 | 5-Amino-1MQ | AXP-WB-20260323-01-95-10 | 98.819% | 108.4%10.84 of 10 mg | 23 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FCBD6F | Epithalon | AXP-TS-20260311-01-74-10 | 98.938% | 118.2%11.82 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F5110B | KLOW Blend | AXP-TS-20260323-01-21-80 | 99.739% | 27.2%21.79 of 80 mg | 20 May 2026 | PASSunder 90% of label | Kovera ↗our verifier → |
| KVR-2026-F04B66 | KPV | AXP-TS-20260311-01-22-10 | 99.527% | 127.3%12.73 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E91AD0 | BPC-157 | AXP-TS-20260323-01-70-10 | 46.849% | 112.8%5.64 of 5 mg | 20 May 2026 | faillab verdict: fail · purity under 95% · over 110% of label | Kovera ↗our verifier → |
| KVR-2026-BACEB2 | TB-500 (Thymosin B4) | AXP-TS-20260311-01-86-10 | 99.933% | 117.8%11.78 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A53D66 | Thymosin alpha-1 | AXP-TS-20260311-01-46-5 | 98.866% | 115.7%11.57 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A37790 | TIR2 or TR2 | AXP-TS-20260311-01-65-20 | 99.883% | 106.6%21.32 of 20 mg | 20 May 2026 | PASSrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-9AF638 | R3TA or G-Series RT3 | AXP-TS-20260311-01-81-50 | 99.144% | 117.9%58.94 of 50 mg | 20 May 2026 | PASSover 110% of labelrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-98F4D4 | Glutathione | AXP-TS-20260311-01-84-750 | 99.298% | 91.8%688.13 of 750 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-854488 | Semax | AXP-TS-20260311-01-38-10 | 99.828% | 105.1%10.51 of 10 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-850CA6 | CAGR | AXP-TS-20260323-01-8-10 | 99.061% | 107.3%10.73 of 10 mg | 20 May 2026 | PASSrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-7E1DCA | R3TA or G-Series RT3 | AXP-TS-20260323-01-35-10 | 99.629% | 116.8%11.68 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4580E0 | Selank | AXP-TS-20260410-01-92-10 | 99.092% | 119.9%11.99 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3FE373 | TIR2 or TR2 | AXP-TS-20260311-01-64-30 | 99.031% | 106.3%31.88 of 30 mg | 20 May 2026 | PASSrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-2DD1C5 | SERMO | AXP-TS-20260311-01-94-10 | 98.761% | 116.4%11.64 of 10 mg | 20 May 2026 | PASSover 110% of labelrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-233CC5 | CJC-1295 no DAC | AXP-TS-20260327-01-51-5 | 99.391% | 112.8%5.64 of 5 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-12AC8A | SEM1 or SM1 | AXP-TS-20260311-01-61-10 | 99.448% | 114.6%11.46 of 10 mg | 20 May 2026 | PASSover 110% of labelrevised by the lab 2026-06-09, figures unchanged | Kovera ↗our verifier → |